Read about research from the November 2023 ASCO Plenary Series, which explores emerging treatments for advanced myeloma and stomach and gastroesophageal junction cancers.
Dr. Patricia I. Moreno and Dr. Frank J. Penedo discuss survivorship research, including what it is, how it helps address challenges that cancer survivors face, and how to get involved with studies that focus on understanding and improving the lives of people treated for cancer.
Research from the 2024 ASCO Genitourinary Cancers Symposium will highlight studies that explore treatments for kidney cancer and advanced prostate cancer.
In this podcast, 5 members of the Cancer.Net Editorial Board discuss new research and developments in the treatment of various genitourinary (GU) cancers including prostate cancer, bladder cancer, kidney cancer, and testicular cancer.
Research from the 2024 ASCO Gastrointestinal Cancers Symposium will highlight studies that explore treatment options for people with cancers of the gastrointestinal tract, such as colorectal cancer, esophageal cancer, liver cancer, and neuroendocrine tumors.
In this podcast, Dr. Richard L. Schilsky describes ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR) Study and what has been learned since it launched in 2016.
Read about 2 studies from the November 2023 ASCO Plenary Series, which explore emerging treatments for advanced cancers of the stomach and esophagus.
Research from the 2023 ASCO Quality Care Symposium will highlight studies using text messaging to reduce time spent at the clinic, virtual mind-body fitness to reduce health care visits for people with cancer, and yoga to help reduce side effects of radiation therapy for people with head and neck cancer.
In this podcast, 3 members of the Cancer.Net Editorial Board discuss new research presented at the 2023 ASCO Annual Meeting in non-small cell lung cancer, small cell lung cancer, and mesothelioma.
In this podcast, 2 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting about preventing melanoma recurrence and reducing cancer disparities.
